RESTORIL

This brand name is authorized in Canada, United States

Active ingredients

The drug RESTORIL contains one active pharmaceutical ingredient (API):

1 Temazepam UNII CHB1QD2QSS - TEMAZEPAM

Temazepam is a benzodiazepine with hypnotic and sedative effects as well as anxiolytic activity. Temazepam effects are likely to be due to potentiation of gamma-aminobutyric acid (GABA), although other neurotransmitters may also be affected. Read about Temazepam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RESTORIL Capsule	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CD07	Temazepam	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CD Benzodiazepine derivatives
Discover more medicines within N05CD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00604453, 00604461
Country: US	FDA, National Drug Code	Identifier(s): 0406-9914, 0406-9915, 0406-9916, 0406-9917